Skip to main content
CRIS logo

CRIS · Curis Inc · Metrics

Track CRIS — free
$0.43 -0.04 (-9.03%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$4.06M
Shares
9.51M
Volume · Nov 20 531.09K Avg daily vol (3M) 4.27M

CRIS metrics

70 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.43
Market cap
$4.06M

Price action

23 metrics
Price change (1W)
-4.0%
Price change (30D)
+5.5%
Price change (3M)
-73.0%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$27.40
52-week low
$0.38
Change from 52-week high
-98.4%
Change from 52-week low
+13.2%
Annualized volatility
168.6%
Annualized volatility (3M)
179.9%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
40.4
Price vs SMA 50
-38.4%
Price vs SMA 200
—
Avg volume (3M)
4.27M
Relative volume
0.1
Average dollar volume
$4.01M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
9.51M

Valuation

12 metrics
P / E (TTM)
0.1
Trailing earnings · reciprocal yield 1,384.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.9×
reciprocal yield 106.2%
P / book
1.6
reciprocal yield 62.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-530.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
1,273.2×
reciprocal yield 0.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-12

Profitability

9 metrics
Gross margin
—
Operating margin
-60.5%
Trailing 12 months
Net margin
-80.3%
Gross profit (TTM)
—
Operating profit (TTM)
−$10.59M
Net income (TTM)
−$21.54M
Trailing 12 months
Diluted EPS (TTM)
$5.91
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$5.50
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$6.28
EBITDA per diluted share (TTM)
$-0.36
Net income per diluted share (TTM)
$-6.37
Operating cash flow per diluted share (TTM)
$-23.28
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$18.54
Stock compensation per diluted share (TTM)
$2.00
Book value per share
$0.27

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4.31M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+432.9%
Year over year · more shares
Revenue CAGR (3Y)
-2.4%
Revenue CAGR (5Y)
-2.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-844.5%
Return on assets
-114.6%
Debt / equity
0.0
Current ratio
0.4
EBITDA (TTM)
−$10.53M
Free cash flow (TTM)
—
Quick ratio
0.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$5.01M
Latest balance sheet
Cash & equivalents
$5.01M
Total assets
$18.80M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$30.77M
Capital expenditures (TTM)
—
R&D (TTM)
$24.58M
SG&A (TTM)
—
Stock compensation (TTM)
$2.46M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
28
13F filer change QoQ
-11
Institutional ownership
12.2%
Conviction holders (share of 13F filers)
3.6%
Crowding (high-turnover and private-fund holders)
48.5%
Private-fund adviser ownership
40.1%
Active holders' share change QoQ
+46.1%
Holder tenure
8.1
Price vs estimated holder cost
-95.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.2%

Short interest

3 metrics
Short interest
10.8%
Latest settlement · 1.1 days to cover
Days to cover
1.1d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1108205 CUSIP 231269408 13F (30d) 52 filings 29 filers Visit website Investor relations